0.00Open0.05Pre Close0 Volume6 Open Interest640.00Strike Price0.00Turnover5364.59%IV16.82%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0028Delta0.0002Gamma15387.00Leverage Ratio-309.1605Theta0.0000Rho-43.70Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet